Round table report: What’s next for AI in healthtech

Recently Medilink Midlands CEO Melanie Davidson took place in a round table hosted by The Business Desk. The round table, sponsored by Tank, a digital marketing agency, saw clinicians, academics, healthtech and data security experts discuss the potential benefits of implementing new technologies, focusing specifically on the role of AI,...

InterAct & GW+Co workshop

GW+Co and the InterAct Network will be coming together on Thursday 21st March at the Manufacturing Technology Centre in Coventry to host a workshop examining current perceptions of manufacturing and how 'collaborative design’ through aligning strategy, brand and culture can help your business’ image. Who is this event for? Leaders of...

CBBC Knowledge Exchange Partnership Tour of the Greater Bay Area for UK Innovation Leaders – 9-11 April 2024 – Expression of Interest

The China-Britain Business Council (CBBC) is organising a tour for UK higher education senior leaders for research and international activities, start-ups, entrepreneurial researchers, and innovators to visit the Greater Bay Area (GBA) between the 9-11 April 2024. The theme of the tour is Knowledge Exchange Partnerships (KEP). There will be...

Lil-Lets celebrates 70 years and launches new Organic Cotton range

In 2024 Medilink member Lil-Lets UK limited proudly celebrates 70 years in business and what better way to do so than by bringing new products to market! The company’s latest launch showcases its commitment, understanding and expertise in providing quality, comfortable and absorbent consumer products that also align with sustainability...

Ashfield Enterprise Development Grant Scheme

Ashfield District Council has created an Enterprise Development Grant Scheme in order to provide grants to businesses and social enterprises with viable growth plans leading to the creation of new jobs. This grant scheme will end on 31st March 2025. The closing date for applications is 31st October 2024. Who...

Upperton Pharma Solutions continues growth with appointment of Philip Payne as Chief Commercial Officer

Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions (Upperton) continues its growth following the build of a new 50,000 sq ft GMP manufacturing facility and recent sterile fill-finish capability announcement, with the appointment of Philip Payne as Chief Commercial Officer (CCO). Philip joins Upperton’s leadership team and...